Key facts about Belzutifan
What dosages is Belzutifan available in?
Belzutifan is available as a 40 mg oral tablet.
What is Belzutifan used for?
Belzutifan treats kidney cancer. It may also be used to treat some types of cancer and tumors in people with von Hippel-Landau syndrome.
How does Belzutifan work?
Belzutifan works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.
How do I take Belzutifan?
The recommended dosage of Belzutifan is 120 mg administered orally once daily with or without food.
Is it safe for me to take Belzutifan?
Belzutifan is a safe and effective treatment when used for FDA licensed indications. However, like all medications, they may give you unwanted side effects. You should always discuss potential side effects with your physician to ensure the medication is suitable and right for you.
Belzutifan Common Side Effects
Common side effects of Belzutifan:
- Decreased hemoglobin
- Fatigue
- Increased creatinine
- Headache
- Dizziness
- Increased glucose
- Nausea
Belzutifan Serious Side Effects
Serious side effects are rare with Belzutifan.
- Anemia
- Inform patients that Belzutifan can cause severe anemia that may require blood transfusions and that red
blood cell levels will be monitored routinely during treatment. Advise patients to contact their healthcare
provider if the patient experiences any symptoms suggestive of anemia. - Hypoxia
- Inform patients that Belzutifan can cause severe hypoxia that may require discontinuation, supplemental
oxygen, or hospitalization; and that oxygen levels will be monitored routinely during treatment. Advise
patients to contact their healthcare provider if the patient experiences any symptoms suggestive of
hypoxia
Effects of other drugs, drug classes and over-the-counter products on Belzutifan
The following medications may interact with Belzutifan:
- UGT2B17 or CYP2C19 Inhibitors: Monitor for signs and symptoms of anemia and hypoxia and reduce the dosage of Belzutifan as recommended
Who makes Belzutifan?
Various FDA-approved generic manufacturers
Is Belzutifan safe in pregnancy?
Exposure to Belzutifan during pregnancy can cause
embryo-fetal harm. You should have your pregnancy status verified prior to the initiation of Belzutifan. If you can become pregnant, you should use effective non-hormonal contraception during treatment with Belzutifan and for 1 week after the last dose, since Belzutifan can render some hormonal contraceptives ineffective. Male patients with female partners of reproductive potential shoud use effective contraception during treatment with Belzutifan and for 1 week after the last dose.
